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nitis pigmentosa (RP)- or Leber congenital amaurosis (LCA)-like retinal dystrophy and a medullary cystic
kidney disease, nephronophthisis. Mutations in several genes (called nephrocystins) have been shown to
cause SLS. The proteins encoded by these genes are localized in the connecting cilium of photoreceptor
cells and in the primary cilium of kidney cells. Nephrocystins are thought to have a role in regulating
transport of proteins bound to the outer segment/primary cilium; however, the precise molecular mech-
anisms are largely undetermined. This review will survey the biochemistry, cell biology and existing ani-
mal models for each of the nephrocystins as it relates to photoreceptor biology and pathogenesis of
retinal degeneration.
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Inherited retinal diseases are estimated to affect up to 200,000
people in the United States (http://www.mdsupport.org/library/
numbers.html). A vast majority of these cases are retinitis pigmen-
tosa (RP), which accounts for 40% or 80,000 people. RP is a disease
where the photoreceptors, the light-sensing cells of the eye, die
(Hartong, Berson, & Dryja, 2006). RP clinically presents with nycta-
lopia (night blindness) and progresses to signiﬁcant peripheral vi-
sual ﬁeld reduction (tunnel vision). Central visual acuity and cone
function are often preserved until late in the course of the disease.
Patients with end stage disease will have no light perception at all.
Other clinical ﬁndings on a retinal exam include bone spicule for-
mation (retinal pigmentation), peripheral retinal atrophy, waxy
pallor of the optic disk and optic nerve head drusen and vascular
attenuation (Fig. 1). Diagnosis is done using a detailed clinical
and family history, a dilated retinal examination and photography,
visual ﬁeld testing, electroretinography, optical coherence tomog-ll rights reserved.
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progression or restores vision in patients with RP, and therefore,
prognosis is poor.
RP may associate with development of pathology in other or-
gans (Sattar & Gleeson, 2011). Examples of syndromic RP include
Bardet–Biedl syndrome (BBS), Joubert syndrome (JBTS), Meckel
syndrome (MKS), Usher syndrome (USH) and Senior–Løken syn-
drome (SLS) (Table 1). Bardet–Biedl syndrome is characterized by
RP, obesity, polydactyly, cognitive impairment, male infertility,
and renal abnormalities, among other pathologies (Zaghloul &
Katsanis, 2009). Joubert syndrome presents with hypotonia and
ataxia early in life. Other characteristic features are breathing
problems, abnormal eye movements, and mental retardation. Jou-
bert syndrome is sometimes associated with RP, kidney, and liver
disease, and polydactyly (Doherty, 2009; Juric-Sekhar et al.,
2012) (Table 1). Usher syndrome affects mostly hair cells in the
ear and photoreceptors in the retina causing hearing loss and RP
(Kremer et al., 2006).
Patients with Senior–Løken syndrome develop RP and a kidney
pathology called nephronophthisis. Nephronophthisis (NPHP) is an
autosomal recessive cystic kidney disease and is the most frequent
genetic cause of end-stage renal disease (ESRD) in children and
adolescents. A recent review on nephronophthisis can be found
inWolf and Hildebrandt (2011). The median age for ESRD is around
13 years old. Children clinically present with polyuria, nocturia or
Fig. 1. Fundus photograph of a patient diagnosed with Senior–Løken syndrome.
Shown are classic ﬁndings in RP: bone-spicule shaped deposits, attenuation of
blood vessels with macular sparing.
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mally sized kidneys with increased echogenicity, poor corticome-
dullary differentiation, and corticomedullary cysts and can
progress to atrophic kidneys with more prominent cysts. A kidney
biopsy may show the triad of corticomedullary cysts, tubular base-
ment membrane disruption and interstitial ﬁbrosis. NPHP is diag-
nosed using renal biopsy or by mutational analysis. So far,
mutations in 13 genes (NPHP1–13) are known to cause nephron-
ophthisis, and nine mutant genes are associated with development
of retinal degeneration (Table 2). However, most of the gene muta-
tions are also associated with development of pathology in other
organs besides the kidneys and the retina (Tables 1 and 2). A
majority of the nephrocystins associated with development of ret-
inal degeneration or Senior–Løken syndrome are now known to be
expressed in the photoreceptor connecting cilium, a structural
counterpart of the primary cilium found in most cell types.Table 1
Clinical syndromes associated with development of retinitis pigmentosa. Column 1 shows
the exception in Usher syndrome – not associated with development of nephronophthisis).
in blue in column 3.
Syndrome Gene mutations Other
Bardet Biedl CEP290 (NPHP6), SDCAAG8 (NPHP10) Trunca
hypogo
http://
COACH NEK8 (NPHP9), TMEM67 (NPHP11) Cerebe
ﬁbrosi
Jeune TTC21B (NPHP12), WDR19 (NPHP13) Severe
short s
insufﬁ
60815
Joubert NPHP1, CEP290 (NPHP6), RPGRIP1L (NPHP8), NEK8
(NPHP9), TMEM67 (NPHP11), TTC21B (NPHP12)
Abnorm
movem
muscle
Meckel NPHP3, CEP290 (NPHP6), RPGRIP1L (NPHP8), NEK8
(NPHP9), TMEM67 (NPHP11)
Enceph
entry/2
Renal–hepatic–
pancreatic
dysplasia (RHPD)
NPHP3 Pancre
Senior–Løken NPHP1, INVS (NPHP2), NPHP3, NPHP4, IQCB1
(NPHP5), CEP290 (NPHP6), SDCAAG8 (NPHP10)
Nephro
26690
Sensenbrenner WDR19 (NPHP13) Microc
callosu
limbs,
Usher MYO7A, USH1C, CDH23, PCDH15, SANS, USH2A,
VLGR1, WHRN, USH3A
Hearin2. The photoreceptor connecting cilium
Cilia are composed of nine microtubule doublets (called the
axoneme) in a cylindrical arrangement that emanate from basal
bodies, the microtubule organizing centers of the cell. There are
two types of cilia: motile cilia that are necessary for locomotion
and ﬂuid movement, and non-motile (primary) cilia that serve
mainly sensory functions. Motile cilia have an additional microtu-
bule doublet found in the center of the axonemal cylinder giving it
a characteristic 9 + 2 pattern unlike the 9 + 0 pattern of doublets
found in primary cilia. Nodal cilia (a type of motile cilia) that are
found on cells of the embryonic node were initially thought to have
9 + 0 arrangement but some have recently been found to be 9 + 2
(Caspary, Larkins, & Anderson, 2007; Novarino, Akizu, & Gleeson,
2011; Okada & Hirokawa, 2009). In addition to the central pair of
doublets, motile cilia also have inner and outer dynein arms on
the outer doublets that are required for generation of force neces-
sary for motility. The axonemal structure is anchored at the base by
the basal body or mother centriole.
The connecting cilium (CC) of vertebrate photoreceptors is a
structural homolog of the primary cilium containing the 9 + 0 pat-
tern of microtubule doublets. The CC is 0.5–1.2 lm in length and
approximately 0.2 lm in diameter, connects the biosynthetic inner
segment (IS) to the sensory outer segment (OS). The entire struc-
ture consisting of CC and OS is also called the ‘‘photosensitive cil-
ium’’. It is now recognized that mutations in numerous genes,
which are expressed in the photoreceptor connecting cilium cause
a group of heterogeneous diseases called ciliopathies. Because of
the ubiquitous expression of these genes in primary cilia, ciliopa-
thies often affect multiple organs including kidney, retina, brain,
or spermatozoa. The most prominent syndromic diseases that af-
fect the retina are Joubert syndrome, Bardet–Biedl syndrome, and
Senior–Løken syndrome (Table 1).
Senior–Løken syndrome and the mutations in the genes that are
associated to the development of this disease will be important to
study to understand the basic mechanisms of protein transport
through the connecting cilium. Therefore, it is important to under-
stand the normal function of each of the nephrocystins to under-
stand pathogenesis of retinal degeneration in these patients.various clinical syndromes. Column 2 shows mutations in different NPHP genes (with
Column 3 shows other pathologies in different organs. Links to the sources are shown
pathologies besides RP
l obesity, postaxial polydactyly, cognitive impairment, male hypogonadotropic
nadism, complex female genitourinary malformations, and renal abnormalities
omim.org/entry/209900
llar vermis hypoplasia/aplasia, Oligophrenia, Ataxia, Coloboma, and Hepatic
s http://omim.org/entry/216360
ly constricted thoracic cage (thoracic hypoplasia), short-limbed (brachydactyly),
tature, and polydactyly. It often leads to death in infancy due to respiratory
ciency (chronic nephritis) http://omim.org/entry/612014http://omim.org/entry/
1
ally rapid breathing (hyperpnea), decreased muscle tone (hypotonia), jerky eye
ents (oculomotor apraxia), mental retardation, inability to coordinate voluntary
movements (ataxia) http://omim.org/entry/213300
alocele, hepatic ductal dysplasia and cysts, and polydactyly http://omim.org/
49000
atic ﬁbrosis, renal dysplasia, hepatic dysgenesis http://omim.org/entry/208540
nophthisis and Leber congenital amaurosis (LCA) http://www.omim.org/entry/
0
ephaly, narrow thorax, heart defects, liver ﬁbrosis, hypoplasia of the corpus
m, skeletal abnormalities, including craniosynostosis, narrow rib cage, short
and brachydactyly, and ectodermal defects http://omim.org/entry/614378
g loss and severe balance problems http://omim.org/entry/276900
Table 2
Human and mouse NPHP genes associated with various syndromes or retinal degeneration (RD). Column 1, human gene symbols and most common aliases. Column 2, mouse
genes. Column 3, human and mouse gene loci. Column 4, approximate frequency of patients affected by RD. Column 4, naturally occurring or laboratory generated mouse models.
Column 5, expression of mouse genes in photoreceptors and phenotype of mutants. CC, connecting cilium; BB, basal bodies. Column 6, associated human diseases. Abbreviations
of human pathologies also serve as aliases.
Human gene (aliases) Mouse
genes (aliases)
Locus
human/
mouse
RD
(%)
Mouse
model
Photoreceptor
expression/
phenotype
Associated human
diseases
NPHP1 (nephrocystin 1) Nphp1 (Nph1) 2q13/2 F3 <10 Nphp1/ CC and BB/RD Joubert syndrome (JBTS4), nephronophthisis, juvenile,
Senior–Løken syndrome (SLSN1)
INVS (inversion of embryo
turning protein) (NPHP2)
invs (Nphp2) 9q22-q31/4
B
10 inv/inv CC/unknown Nephronophthisis, infantile, Senior–Løken syndrome
(SLSN2)
NPHP3 Nphp3 (Pcy) 3q22/9 <20 pcy CC/unknown Nephronophthisis, adolescent, Senior–Løken syndrome
(SLSN3),
Meckel syndrome (MKS7), Renal–hepatic–pancreatic
dysplasia
Nphp3/ (embryonic
lethal)
NPHP4 (POC10) Nphp4 1p36/4 <40 Nphp4/ BB/RD Nephronophthisis, Senior–Løken syndrome (SLSN4),
Cogan syndrome
IQCB1 (IQ motif containing B1)
(NPHP5)
Iqcb1 3q21.1/16
B3
100 None CC and OS/RD Senior–Løken syndrome (SLSN5), Leber congenital
amaurosis (LCA10)
CEP290 (centrosomal protein 290)
(NPHP6)
Cep290 Nphp6,
rd16
12q21.32/
10 D1
100 rd16 CC and BB/RD Nephronophthisis, Meckel syndrome (MKS4), Senior–
Løken syndrome
(SLSN6), Leber congenital amaurosis (LCA 10),
Bardet–Biedl syndrome
(BBS14), Joubert syndrome (JBTS5)
GLIS2 (GLIS family zinc ﬁnger 2)
(NPHP7)
Glis2 (Nphp7) 16p13.3/16 0 Nphp7/ Unknown Nephronophthisis
RPGRIP1L (RP GTPase
regulator-interacting
1 like protein) (NPHP8)
Rpgrip1l
(Nphp8, ftm)
16q12.2/8 <10 ftm CC/none Nephronophthisis, Meckel syndrome (MKS5), Joubert
syndrome (JBTS7)Rpgrip1l/

(embryonic
lethal)
NEK8 (NIMA (never in mitosis
gene a) – related kinase 8) (NPHP9)
Nek8 (Nphp9;
jck)
17q11.1/
11B5
0 jck CC/none Nephronophthisis, COACH syndrome, Meckel syndrome,
Joubert syndrome
SDCAAG8 (serologically deﬁned
colon cancer antigen 8) (NPHP10)
Sdcaag8 Nphp10 1q43/1H3 100 No BB/unknown Nephronophthisis, Senior–Løken syndrome (SLSN7),
Bardet Biedl syndrome (BBS16)
TMEM67 (NPHP11) (Meckelin) Tmem67 (Bpck) 8q21.1/4 0 Bpck Unknown/RD Meckel syndrome (MKS3), Joubert syndrome (JBTS6),
Nephronophthisis, COACH syndromewpk (rat) Unknown/RD
TTC21B (tetratricopeptide repeat
domain 21B) (NPHP12)
Ttc21b (aln) 2q24.3/2 0 aln (embryonic
lethal)a
Nephronophthisis, Jeune syndrome (ATD4),
Joubert syndrome (JBTS11)
WDR19 (WD repeat domain 19)
(NPHP13) (IFT144)
Wdr19 4p14-p11/5 <50 No Unknown Jeune syndrome (ATD5), Sensenbrenner syndrome,
nephronophthisis
a The aln mouse is lethal at E18.5 so retinal and renal phenotype cannot be determined; there is a knockdown model in the rat that has retinal degeneration.
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By positional cloning, several mutations in NPHP genes have
been found to cause nephronophthisis (Hildebrandt, Attanasio, &
Otto, 2009). The mutations which cause disease are inherited in
an autosomal recessive pattern. Transmission can be monogenic
(i.e. homozygous and compound heterozygous mutations) or
digenic (i.e., heterozygous mutations in two different genes). These
genes include NPHP1, Inversin/NPHP2, NPHP3, NPHP4, IQCB1/NPHP5,
CEP290/NPHP6, GLIS2/NPHP7, RPGRIP1L/NPHP8, NEK8/NPHP9,
SDCAAG8/NPHP10, TMEM67/NPHP11, TTC21B/NPHP12, and
WDR19/NPHP13. The frequency of RP with nephronophthisis
(Senior–Løken syndrome) depends on which nephrocystin gene
is mutated. The frequency of retinal dystrophy in NPHP1–4 is less
than 40% and reaches 100% in NPHP5 and NPHP6 mutations
(Table 2). It should be noted that mutations in each of the nephro-
cystin genes may give rise to heterogeneous phenotypes and even
different syndromes. Abnormalities in multiple organs may devel-
op including the retina, brain, liver and heart (Table 2). For exam-
ple, NPHP6/CEP290 mutations may be associated with isolated
Leber congenital amaurosis (LCA), Senior–Løken syndrome (SLS)
or the lethal multi-systemic Meckel–Gruber syndrome (MKS)
(Table 1). The presence of modiﬁer alleles (quantitative trait loci,
QTL) may further contribute to the complexity of the ciliopathies.
In contrast, mutations in NPHP5 are only associated with develop-
ment of the retinal–renal disease phenotype making this gene the
classic Senior–Løken gene (Wolf & Hildebrandt, 2011).3.1. NPHP1
Nephronophthisis, ﬁrst described by Fanconi (Fanconi et al.,
1951) in1951, is caused by mutations in 13 distinct and unrelated
genes (Table 2) (Wolf & Hildebrandt, 2011). Juvenile nephronoph-
thisis is caused by mutations in nephrocystin-1 (NPHP1), the ﬁrst of
the nephronophthisis genes discovered (Hildebrandt et al., 1997).
End stage renal disease (ESRD) develops at an age of approximately
13 years. NPHP1 is located on chromosome 2q13, contains 20
exons, and produces a 4.5 kb-transcript encoding an 83 kDa pro-
tein. NPHP1 contains an SH3 domain (Hildebrandt et al., 1997), a
coiled-coil domain in the N-terminus and a highly conserved C-ter-
minal domain called a nephrocystin homology domain (NHD)
(Donaldson et al., 2002). The major gene defect observed in juve-
nile nephronophthisis is a large homozygous deletion in the NHD
region of NPHP1 (Otto, Betz, et al., 2000). Deletion of this region
is also associated with development of Cogan syndrome with
nephronophthisis (Betz et al., 2000).
In the mouse embryo, NPHP1 is widely and uniformly ex-
pressed; in the adult mouse, there is strong expression in testes
(Otto, Betz, et al., 2000; Otto, Kispert, et al., 2000). In retina, NPHP1
is expressed in photoreceptors and localizes to the connecting cil-
ium in close proximity to the basal body (Fliegauf et al., 2006). This
may explain why a subset of patients with NPHP1mutations devel-
ops retinal degeneration. Targeted disruption of NPHP1 in the
mouse (deletion of the last C-terminal exon 20) did not produce
nephronophthisis, but exhibited rapid retinal degeneration start-
ing at P14-P21(Jiang et al., 2008) and caused male infertility (Jiang
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ment (OS) but the axoneme of the connecting cilium was still pres-
ent in the mutant photoreceptors. At 8 months of age, there is an
almost complete absence of the OS and inner segment (IS) (Jiang
et al., 2008). Rhodopsin, transducin and other phototransduction
proteins destined for the OS were predominantly located in the
IS at P14, before signiﬁcant degeneration of photoreceptor cells be-
gan (Jiang et al., 2008). However, myosin VIIA, RPGR, KIF3A, cen-
trin-1, and WDR19 localized normally to the connecting cilium.
At P14, there was signiﬁcant increase of apoptosis in photoreceptor
cells which correlates to the increased amount of rhodopsin mislo-
calized in the IS (Jiang et al., 2008).
The Nphp1/ retinal phenotype was rescued after crossing the
NPHP1 mutant mice with a transgenic mouse expressing GFP-
tagged NPHP1 (Jiang et al., 2008) showing speciﬁcity of the effect
of a targeted disruption in NPHP1. Another important observation
in these mice was the mislocalization of speciﬁc IFT (intraﬂagellar
transport) particles along the connecting cilium. These include
IFT88 but not IFT122 which suggests that NPHP1 may regulate a
speciﬁc subset of IFT particles and their associated cargos destined
to the OS (Donaldson et al., 2002; Jiang et al., 2008). Importantly,
nephrocystin-1 depletion does not completely abolish photorecep-
tor ciliogenesis and IFT, it only affects the transportation efﬁciency
and sorting mechanism of IFT (Jiang et al., 2008).
3.2. INVS/NPHP2
Genetic linkage to infantile nephronophthisis type 2, which is a
form of nephronophthisis that clinically presents before the age of
5 years, has been mapped to 9q31 (Haider et al., 1998). The gene
associated with this disease was identiﬁed as INVS and shown to
produce a 5.5 kb transcript encoding a 1065 amino acid protein,
inversin/NPHP2 (Otto et al., 2003). In human, two transcript vari-
ants encoding distinct isoforms (long form, 1065 amino acids,
and short form, 895 amino acids) have been identiﬁed for this
gene. The shorter form lacks an in-frame segment in the coding re-
gion. The mouse genome contains only the long form transcript
(1062 amino acids) (Morgan et al., 1998). The protein contains
multiple domains and protein-binding motifs including 16 tandem
ankyrin repeats in the N-terminus, 2 putative nuclear localization
signals (Morgan et al., 1998), 2 IQ-type calmodulin-binding do-
mains (Morgan, Goodship, et al., 2002), and 2 D-box domains
(one is important for binding Apc2, a subunit of the anaphase pro-
moting complex, APC) (Morgan, Eley, et al., 2002). The NPHP2 gene
is conserved in chimpanzee, dog, cow, mouse, rat, chicken, zebra-
ﬁsh, and Caenorhabditis elegans.
The inv/invmouse, which has a deletion of exons 4–12 (of 17 to-
tal) in the Invs gene (Morgan et al., 1998), resembles the human
disease with renal cysts, hepatobiliary duct malformations and
other renal histopathological features (Phillips et al., 2004). It also
has been shown that recessive mutations in INVS cause infantile
nephronophthisis with or without presence of situs inversus in pa-
tients, a classic ﬁnding in ciliopathies (Otto et al., 2003). Moreover,
disruption of invs in zebraﬁsh also causes renal cyst formation
(Otto et al., 2003). NPHP2/Inversin is expressed in the retina as
shown by ﬂuorescence microscopy using an inversin: GFP trans-
genic mouse line (Watanabe et al., 2003). However, there is no re-
port of a retinal phenotype in the loss-of-function inv/inv mouse
and zebraﬁsh models. There has only been one known case of a
mutation in NPHP2 (in exon 13, R907X) causing retinal degenera-
tion (SLS) suggesting that there may be genetic modiﬁers in the
background of NPHP2mutations which lead to development of ret-
inal pathology (O’Toole et al., 2006).
Inversin/Nphp2 accumulates at the base of the primary cilium
(termed the Inv compartment) and acts as an anchor for NPHP3
and NPHP9/NEK8 in this compartment (Sang et al., 2011; Shibaet al., 2010). Inversin/Nphp2 has not been found to affect formation
or maintenance of the renal primary cilia in the inv/invmouse. This
suggests that Inversin/Nphp2 is not necessary for regulating struc-
ture of the primary cilia (Morgan, Goodship, et al., 2002). Inversin
also colocalizes with NPHP1 and b-tubulin in the primary cilium of
MDCK cells (Otto et al., 2003), and with IQCB1/NPHP5 and B9d2, a
MKS1-related protein, in zebraﬁsh photoreceptors (Zhao & Malicki,
2011).
The ERK pathway, known to regulate cell proliferation, has been
thought to play a role in cyst formation. In the inv/inv mouse
expressing a C-terminal truncated form of INVS, the ERK pathway
is activated (Watanabe et al., 2003). After administration of a
MAP kinase inhibitor there was decreased ERK phosphorylation
and inhibition of renal cyst progression (Watanabe et al., 2003). Fi-
nally, the canonical Wnt/b-catenin signaling pathway is also acti-
vated in renal cells of a patient with NPHP2 suggesting a role of
this pathway in cyst formation (Bellavia et al., 2010; Simons
et al., 2005). However, there is very little data on the role of the
ERK and Wnt/b-catenin signaling pathways in photoreceptor cells,
cells that are no longer proliferating.3.3. NPHP3
NPHP3 is associated with adolescent nephronophthisis that
causes ESRD at a median age of 19 years old (Morgan et al.,
1998). The NPHP3 gene was mapped on chromosome 3q22 (Omran
et al., 2000). The NPHP3 gene (28 exons) generates a 6.5 kb tran-
script encoding a 1330-amino acid protein (Olbrich et al., 2003).
It is expressed in the retina suggesting that it contributes to devel-
opment of Senior–Løken syndrome (Olbrich et al., 2003). Linkage to
the NPHP3 locus has been shown in families with Senior–Løken
syndrome (Omran et al., 2002).
NPHP3 contains several protein–protein interaction domains
including an N-terminal coiled-coil domain, a C-terminal tetratrico
peptide repeat domain and a tubulin–tyrosine kinase domain
(Olbrich et al., 2003). Furthermore, it is N-terminally myristoylated
and interacts with the acyl-binding proteins UNC119A and
UNC199B (Wright et al., 2011). Both UNC119A and UNC119B con-
tain immunoglobulin-like hydrophobic binding pocket to accom-
modate acyl side chains (Wright et al., 2011). Targeting to
primary cilia is controlled by N-terminal myristoylation as a
NPHP3 (G2A) mutant did not target to cilia (Nakata et al., in press).
Knockdown of UNC119B also prevented cilia targeting, suggesting
that both myristoylation of NPHP3 and interaction with the myri-
stoyl-binding protein UNC119B is important for targeting (Nakata
et al., in press; Wright et al., 2011). Furthermore, Wright et al.
showed that the GTP-binding protein ARL3 and its GTPase activat-
ing protein (GAP), retinitis pigmentosa 2 protein (RP2), are in-
volved in release of cargo from UND119B (Wright et al., 2011).
Nephrocystin-3 also interacts with NPHP2/inversin, and like inver-
sin, can inhibit canonical Wnt signaling (Bergmann et al., 2008).
The pcy mouse, a spontaneous mouse cystic kidney disease
model, produces a phenotype that resembles the disease progres-
sion of NPHP3 in humans (Omran et al., 2001). Synteny has been
demonstrated in the human NPHP3 and mouse pcy loci (Omran
et al., 2001). However, there is no report of retinal pathology in
the pcy mouse. The pcy mutation is a hypomorphic most likely
caused by a missense mutation (Olbrich et al., 2003). Generation
of an NPHP3 loss-of-function mouse is embryonic lethal with addi-
tional phenotypes of situs inversus and congenital heart defects
(Bergmann et al., 2008). In contrast to NPHP1 and NPHP2, loss of
function of NPHP3 shows a defect in the primary cilium length sug-
gesting a role in regulating the structure of the primary cilium
(Bergmann et al., 2008). Knockdown of nephrocystin-3 in Xenopus
laevis or zebraﬁsh showed defective convergent extension, which is
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polarity defects) (Bergmann et al., 2008; Zhou et al., 2010).
3.4. NPHP4
NPHP4 is located in chromosome 1p36 and encodes a 1250-
amino acid protein called nephrocystin-4 (Mollet et al., 2002;
Schuermann et al., 2002). Development of Senior–Løken syndrome
has been shown to associate to this region (Mollet et al., 2002; Otto
et al., 2002). NPHP4 has a proline-rich region known to bind SH3
domains and is thought to mediate its binding with NPHP1 (Mollet
et al., 2002).
Nephrocystin-4 interacts with p130Cas and Pyk2, proteins in-
volved in cell–cell adhesion (Mollet et al., 2005). It is also known
that NPHP4 negatively regulates Pyk2-dependent tyrosine phos-
phorylation of NPHP1, which is important for localization of
NPHP1 to a trans-Golgi interacting protein (Liebau et al., 2011).
NPHP4 localizes to the renal epithelial cell’s periphery, primary
cilium (where it colocalizes with a-tubulin) and the basal body
(Keller et al., 2005; Mollet et al., 2005). NPHP1 and NPHP4 also
associate with other tight junction proteins such as PALS1/PATJ
and Par6 (Delous et al., 2009). Similar to NPHP2/inversin, NPHP4
is thought to regulate the canonical and non-canonical Wnt-signal-
ing pathways (Burckle et al., 2011).
NPHP4 interacts with the Retinitis GTPase Regulator (RPGR) and
RPGR-Interacting Protein 1 (RPGRIP1) and may provide the link to
development of retinal degeneration in patients with a mutation in
NPHP4 (Murga-Zamalloa, Swaroop, & Khanna, 2009; Roepman
et al., 2005). RPGR mutations cause over 70% of X-linked RP cases
(Murga-Zamalloa, Swaroop, & Khanna, 2009). Mutations in
RPGRIP1 are linked to development of Leber congenital amaurosis
(LCA) where both rod and cone photoreceptors degenerate early in
life (Roepman et al., 2005). RPGRIP1 is localized to the photorecep-
tor connecting cilia associated with the ciliary axoneme (Hong
et al., 2001). Mutations in either NPHP4 or RPGRIP1 abolish this
interaction (Roepman et al., 2005).
A loss-of-function mouse model of NPHP4 (Nphpnmﬂ92) shows
severe retinal degeneration reminiscent of LCA, with mislocaliza-
tion of rhodopsin and ROM1 to the IS (Won et al., 2011). Connect-
ing cilia and ribbon synapses developed normally, but OS failed to
develop and ribbon structures eventually degenerated. However,
as in NPHP1 and NPHP6 mouse mutants, no renal pathology was
observed in the Nphpnmﬂ92 mouse (Chang et al., 2006; Jiang
et al., 2008; Won et al., 2011).
3.5. IQCB1/NPHP5
Located on human chromosome 3, the NPHP5 gene encodes a
69kD protein called nephrocystin-5 or NPHP5 (also referred to as
IQCB1) (Otto et al., 2005). By sequence analysis, it was found that
NPHP5 contains two IQ-calmodulin binding regions (similar to
inversin/NPHP2) and several coiled–coiled domains thought to be
important for protein–protein interactions (Otto et al., 2005). In
contrast to NPHP1–4 where approximately 10–33% of patients de-
velop retinal degeneration, Senior–Løken syndrome is thought to
develop in 100% of patients with NPHP5 mutations (Hildebrandt,
Attanasio, & Otto, 2009). Moreover, unlike the other nephrocystin
genes, which may involve multiple organs, NPHP5 mutations only
associate with the retinal–renal phenotype, making this the classic
Senior–Løken gene (Hildebrandt, Attanasio, & Otto, 2009). NPHP5
mutations in isolated cases of LCA (without nephronophthisis) have
also been found (Estrada-Cuzcano et al., 2011; Stone et al., 2011).
NPHP5 is expressed in the photoreceptor connecting cilia (Otto
et al., 2005). It is known to interact with calmodulin, NPHP6 and
RPGR, other proteins involved in development of retinal degenera-
tion (Murga-Zamalloa et al., 2010; Schafer et al., 2008). Knockdownof NPHP5 in zebraﬁsh causes mislocalization of opsin suggesting its
role in speciﬁc transport of proteins to theOS (Zhao&Malicki, 2011).
3.6. CEP290/NPHP6
The NPHP6/Cep290 gene spans nearly 100 kb and consists of 54
exons, and is located in chromosome 12q21.32 (Sayer et al., 2006).
Null mutations in NPHP6 have been linked in a cohort of patients
with nephronophthisis, Joubert syndrome, Meckel syndrome or Se-
nior–Løken syndrome (Baala, Audollent, et al., 2007; Helou et al.,
2007; Sayer et al., 2006) (Table 1). Hypomorphic NPHP6 mutations
have been found in isolated LCA patients (den Hollander et al.,
2006). The NPHP6/Cep290 gene encodes a 2,472-amino acid pro-
tein, which contains several putative coiled-coil domains, an ATP/
GTP binding loop (P-loop) and a C-terminal myosin-tail homology
domain among others (Chang et al., 2006; Sayer et al., 2006).
NPHP6 is localized in the photoreceptor connecting cilium and
associates with dynein-dynastic and kinesin-II molecular motor
subunits, RPGR, RPGRIP, and NPHP5 (Chang et al., 2006; Moradi
et al., 2011; Murga-Zamalloa et al., 2010; Schafer et al., 2008).
NPHP6 also directly interacts with the transcription factor ATF4
and mediates activation of ATF4 targets (Sayer et al., 2006). A novel
CEP290 interacting partner, Rkip (Raf-1 kinase inhibitory protein),
was recently discovered (Murga-Zamalloa et al., 2011).
Loss-of-function cep290 morpholino knockdowns in zebraﬁsh
exhibited renal, retinal and cerebellar anomalies reminiscent of
the clinical ﬁndings in Joubert syndrome (Sayer et al., 2006), such
as reduced Kupffer’s vesicle size, delays in melanosome transport
and visual impairments (Baye et al., 2011). Interestingly, the N-ter-
minal region of human CEP290 was able to restore vision (Baye
et al., 2011). In a Chlamydomonas reinhardtii null mutant, ﬂagella
were shown to have abnormal levels of IFT and ciliopathy-associ-
ated proteins (Craige et al., 2010). The rd16 mouse, which has an
in-frame deletion of exons 35–39 also develops an early-onset ret-
inal degeneration phenotype (CEP290-LCA) associated with kidney
and cerebellar abnormalities (Chang et al., 2006). This deletion re-
moves part of the C-terminal myosin-tail homology domain of
NPHP6 which interacts with MKKS, a protein associated with
BBS6 (Rachel et al., 2012). Another naturally occurring Cep290mu-
tant is the Abyssinian retinal degeneration cat model (rdAc) (Narf-
strom, 1983). The retina phenotype of the mutant cat resembles a
slowly developing recessive RP, with reduced ERG a-wave ampli-
tudes at 7 months, and complete photoreceptor degeneration at
3–5 years of age. The CEP290 gene defect was recently identiﬁed
as a missense mutation in intron 50, generating a new splice site,
a 4 bp insertion and a CEP protein that is shortened by 159 amino
acids (Menotti-Raymond et al., 2007).
3.7. GLIS2/NPHP7
NPHP7/GLIS2 encodes a 3.8 kb transcript containing 6 exons. The
protein, a 55 kDa Krupel-like transcription factor is important for
kidney development (Zhang et al., 2002). Mutations in GLIS2/
NPHP7 cause nephronophthisis in humans (Attanasio et al., 2007)
without reports of association of retinal degeneration. The GLIS2/
NPHP7 loss-of-function mouse recapitulates the human disease
with atrophic kidneys and presence of ﬁbrosis (Attanasio et al.,
2007). It is not known whether GLIS2/NPHP7 is expressed in the
mammalian retina and is currently not known whether it has an
important role in photoreceptor development and maintenance.
3.8. RPGRIP1L/NPHP8
The NPHP8/RPGRIP1L (retinitis pigmentosa GTPase regulator-
interacting protein-1 like) is located on chromosome 16q12.2 with
35 exons. It encodes a protein with 1315 amino acids. RPGRIP1L/
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with RPGRIP, but overall sequence similarity is relatively low (31%)
(Arts et al., 2007). The protein further contains ﬁve coiled-coil do-
mains in the N-terminus and an RPGR-interacting domain (RID) in
the C-terminus (Delous et al., 2007). By RT-PCR, RPGRIP1L is ex-
pressed in retina, kidney and brain (Arts et al., 2007).
RPGRIP1L/NPHP8 is known to interact with NPHP4 and NPHP6/
CEP290.Whenexpressed individually inCOScells,NPHP8/RPGRIP1L
is soluble, but when co-expressed with NPHP4, it localizes to basal
bodies and cilia suggesting that NPHP4 recruits RPGRIP1L/NPHP8
to these structures. In photoreceptors, RPGRIP1L/NPHP8 localizes
to the photoreceptor connecting cilium, basal body, in the ONL and
the synaptic region, areas where other NPHP gene products, partic-
ularly NPHP4 are located (Arts et al., 2007; Delous et al., 2007).
Loss-of-function mutations in RPGRIP1L/NPHP8 cause Joubert
syndrome (JBTS) or Meckel syndrome (MKS), ataxia and abnormal
eye movements (Arts et al., 2007; Delous et al., 2007; Wolf et al.,
2007) (Table 1) consistent with the notion that it is required for
normal brain and kidney development. In Rpgrip1l knockout mice
(ftm, fantom or fused tow mouse), fetuses had head abnormalities
and very small or non-existing eyes (Delous et al., 2007). Patients
with NPHP8/RPGRIP1L null alleles do not develop RP; however, an
A229T variant is associated with photoreceptor cell loss (Khanna
et al., 2009). This mutation compromises interaction with RPGR
and causes degeneration. Absence of the mutation is thought to
have a protective effect from RP (Khanna et al., 2009).
3.9. NEK8/NPHP9
Mutations in human NEK8/NPHP9 are associated with develop-
ment of nephronophthisis (Otto et al., 2008). It is not clear whether
mutations in NEK8/NPHP9 cause Senior–Løken syndrome. Of the
three patients reported with mutations in this gene, one patient
with a heterozygote mutation in NEK8/NPHP9 developed RP and
was blind at 24 years of age; however, this patient also contained
an additional homozygous mutation in NPHP5 (Otto et al., 2008).
NEK8/NPHP9 is a serine/threonine protein kinase and a member
of the NIMA (never in mitosis-A)-related kinase (Nek) family.
NEK8/NPHP9 encodes a 692 amino acid protein, which contains
an N-terminal catalytic (kinase) domain, several RCC1-like do-
mains (RCC1 is a guanine nucleotide exchange factor for Ran
GTPase) and a coiled-coil domain in the C-terminus (Holland
et al., 2002). Members of this family are thought to regulate coor-
dination of cilium formation and the cell cycle. Like other nephro-
cystin proteins, NEK8/NPHP9 are localized to the primary cilium. It
is not known whether it is expressed in photoreceptor cells of the
mammalian retina.
Mutations in NPHP9/NEK8 occur in the juvenile cystic kidney
(jck) mouse, a model of autosomal recessive cystic kidney disease
(Atala et al., 1993). Knockdown studies in zebraﬁsh produce devel-
opment of pronephric cysts (Liu et al., 2002); however, in both jck
and zebraﬁsh models, retinal pathology has not been reported. It is
more likely that mutations in NPHP9/NEK8 are not associated with
development of retinal degeneration in humans, which correlates
well with the vertebrate models.
3.10. SDCCAG8/NPHP10
Truncating mutations in SDCCAG8/NPHP10 have been found in
several families with nephronophthisis and associated pathologies
including retinal degeneration (Otto et al., 2010). Mutations in
SDCCAG8/NPHP10 have also been found in Bardet–Biedl syndrome
(BBS) (Schaefer et al., 2011). The SDCCAG8/NPHP10 gene produces
a 3.3 kb transcript encoding an 88 kDa protein containing an N-ter-
minal globular domain, a nuclear localization signal and eight
putative coiled-coil domains (Otto et al., 2010).SDCCAG8/NPHP10 is localized to the connecting cilium area in
photoreceptor cells particularly in the basal body and transition
zone (Otto et al., 2010). It also has been shown that it co-localizes
with other proteins associated with development of retinal degen-
eration including NPHP5, RPGRIP and RP1 (Otto et al., 2010).
Knockdown of SDCCAG8/NPHP10 in zebraﬁsh resulted in kidney
cysts, hydrocephalus as well as other developmental problems
but no retinal phenotype has been reported (Otto et al., 2010).
3.11. TMEM67/NPHP11
Hypomorphic mutations in TMEM67/NPHP11 cause nephron-
ophthisis with associated liver ﬁbrosis (Otto et al., 2009) as well
as other diseases in the ciliopathy spectrum including Meckel–
Gruber syndrome (Smith et al., 2006) and Joubert syndrome (Baala,
Romano, et al., 2007). Out of the 12 individuals found with a muta-
tion in TMEM67/NPHP11, three patients developed retinal degener-
ation/blindness (Otto et al., 2009).
TMEM67/NPHP11 is located in chromosome 8q22 and tran-
scribed into two isoforms. The longer isoform 1 (28 exons) contains
995 amino acids and the shorter isoform 2 (29 exons) contains 914
amino acids. In the shorter isoform, the three N-terminal exons of
isoform 1 are replaced by two alternate exons. The protein encoded
by the isoforms, called Meckelin, is a transmembrane protein pre-
dicted to have an extracellular region with four N-liked glycosyla-
tion sites, seven transmembrane regions and a short cytoplasmic
tail (Smith et al., 2006).
The TMEM67/NPHP11 locus is syntenic to theWpk (Wistar poly-
cystic kidney) locus in rat, which carries a hypomorphic mutation
(P394L) that produces polycystic kidney disease, agenesis of the
corpus callosum and hydrocephalus (Gattone et al., 2004; Nauta
et al., 2000). Further, the Wpk photoreceptors showed advanced
retinal degeneration at 3 weeks of age (Tammachote et al., 2009).
A spontaneous deletion of TMEM67/NPHP11 in mouse (bpck
mouse – bilateral polycystic kidneys) has also been reported with
phenotypes that resemble the human disease (polycystic kidney
and hydrocephalus) (Cook et al., 2009). The photoreceptors in bpck
mice degenerate very early with complete absence of the OS at P24
and reduction of the axonemal tip in the connecting cilia at P14
(Collin et al., 2012). However, at P14, the structure of the CC and
the basal body was normal. Rhodopsin and ROM1 were mislocal-
ized at P12, but RPGR, RPGRIP1L and ALMS1 located normally to
the CC. At this age, mutant OS were disorganized and arrestin
and transducin failed to translocate in the photoreceptors when
exposed to light (Collin et al., 2012). Cone photoreceptors were also
affected in the bpck retina. Both ML-opsin and S-opsin were mislo-
calized and cone outer segments appeared shortened (Collin et al.,
2012). These results suggest that NPHP11, like other of the nephr-
ocystin proteins in photoreceptors are important in regulation of
protein trafﬁcking.
3.12. TTC21B/NPHP12
TTC21B/NPHP12 (tetratricopeptide repeat domain 21B) located
on chromosome 2q24.3 contains 29 coding exons and encodes
IFT139, a 150 kDa retrograde intraﬂagellar transport (IFT) protein
(Davis et al., 2011). TTC21B/NPHP12 contains eleven tetratricopep-
tide (TPR) domains and is important for mediating protein–protein
interactions and assembly of multimeric complexes. Mutations in
NPHP12/TTC21B/THM1 cause disease phenotypes in the ciliopathy
spectrum including isolated nephronophthisis and Jeune syndrome
(asphyxiating thoracic dystrophy) (Davis et al., 2011) (Table 1).
Mutations in this gene also contribute as a modiﬁer allele with
other disease-causing genes (Davis et al., 2011).
In IMCD3 cells, NPHP12/TTCB21B colocalizes with Acetyl-tubu-
lin in cilia, and was shown to be present throughout the axoneme,
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ing in NPHP12/TTCB21B-deﬁcient IMCD3 cells revealed IFT88-EYFP
at the distal ends of cilia, consistent with impairment of retrograde
IFT (Tran et al., 2008).
The alienmouse (aln), an NPHP12/TTC21B null mutant generated
by ENU mutagenesis, is embryonic lethal at E18.5. Aln shows skel-
etal abnormalities, neural tube defects as well as delayed develop-
ment of the eye and brain (Tran et al., 2008), similar to the
hallmark features in individuals with Jeune syndrome. In rodents,
speciﬁc knockdown of NPHP12/TTC21B show abnormal photore-
ceptor structure (Davis et al., 2011).
3.13. WDR19/NPHP13
WDR19/NPHP13 belongs to the family of WD-repeat proteins.
The WDR domain consists of a conserved 40 amino acids domain
ﬂanked by glycine–histidine and tryptophan-aspartic acid dipep-Fig. 2. Motif and domain structure of NPHP proteins. The nephrocystins contain the f
nephrocystin homology domain (NHD) (Otto, Kispert, et al., 2000). INVS/NPHP2, ANK, N-t
calmodulin-binding motifs (IQ) (Lienkamp, Ganner, & Walz, 2012; Otto et al., 2003). NPH
TPR, tetratricopeptide repeat domains (Olbrich et al., 2003; Wright et al., 2011). NPHP4
calmodulin binding motifs (Otto et al., 2005). NPHP6, multiple CDs throughout the molec
ﬁnger motifs (Zhang et al., 2002). NPHP8, S_TKc, N-terminal serine/threonine protein ki
domain (Zalli, Bayliss, & Fry, 2012). NPHP10, NGD, N-terminal globular domain; eight
NPHP12, TPR, tetratricopeptide domains (Davis et al., 2011). NPHP13, WDR, WD repeatstides (WD) (Lin et al., 2003). WD-repeat containing proteins are
thought to be important in vesicle formation and vesicular trafﬁck-
ing (Lin et al., 2003). The WDR19/NPHP13 gene contains 36 exons
located on chromosome 4p15–4p11. It encodes IFT144, a protein
containing six WD repeats, a clathrin heavy-chain repeat and three
transmembrane domains (Lin et al., 2003). IFT144 is a member of
the intraﬂagellar transport (IFT) complex A (Bredrup et al., 2011).
Proteins in the IFT-A complex regulate retrograde ciliary transport
in contrast to the IFT-B complex, which regulate anterograde
transport.
Compound heterozygous mutations in WDR19/NPHP13 have
been shown to associate with development of Sensenbrenner syn-
drome characterized by renal insufﬁciency leading to chronic renal
failure (nephronophthisis-like), RP and various skeletal anomalies
including polydactyly, short ﬁngers, and other bone abnormalities
(Bredrup et al., 2011). Compound heterozygous and homozygous
missense mutations in WDR19/NPHP13 have also been identiﬁedollowing predicted motifs: NPHP1, coiled-coil (CD), SRC Homology 3 (SH3) and a
erminal Ankyrin repeat, ICP4, transcriptional regulator domain, ﬂanked by CD and IQ
P3, myr, N-terminal myristoylation signal; CD; TTL, tubulin-tyrosine ligase domain;
, PR, proline-rich region (Mollet et al., 2002). NPHP5, a CD domain ﬂanked by 2 IQ
ule; myo tail, myosin tail homology domain (Chang et al., 2006). NPHP7, several Zinc
nase catalytic domain; RCC1, C-terminal Regulator of chromosome condensation 1
CDs (Otto et al., 2010). NPHP11, TM, transmembrane domains (Otto et al., 2009).
(Lin et al., 2003).
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with similar clinical ﬁndings as that of Sensenbrenner syndrome
(Bredrup et al., 2011).
WDR19/NPHP13 localizes to the primary cilium of ﬁbroblast
cells and when absent, negatively affects cilia formation (Bredrup
et al., 2011). In disease-causing mutations, which still express the
protein, IFT-B particles accumulate in the tip of cilia highlighting
the importance of WDR19/NPHP13 in retrograde trafﬁcking.
Of the six patients with WDR19/NPHP13 mutations associated
with disease development (Sensenbrenner, isolated nephronoph-
thisis and Jeune syndrome), three develop retinal abnormalities
(50%) with two being diagnosed with RP (Bredrup et al., 2011). It
is not known whether NPHP13/WDR19 localizes to the photore-
ceptor connecting cilium; however, presumably, it may have an
important role in retrograde protein trafﬁcking in photoreceptor
cells, although retrograde IFT in photoreceptors may be less signif-
icant as outer segments are constantly phagocytosed (Kevany &
Palczewski, 2010). It will be important to elucidate proteins which
NPHP13/WDR19 bind and transport from the photoreceptor OS to
IS. Also, animal models will be important in elucidating the molec-
ular mechanism of NPHP13/WDR19.4. Conclusions and perspectives
Thirteen nephrocystin (NPHP) genes have been identiﬁed to
date and shown to be associated with nephronophthisis, Senior–
Løken, Bardet–Biedl, Joubert and Meckel syndromes, among others
(Table 1). These NPHP genes express a variety of proteins which are
unrelated by sequence, domain structure, or protein interaction
motifs. The proteins have been exhaustively analyzed for motifs
to gather clues about their function, and their genes have been de-
leted or knocked down in mouse, zebraﬁsh, worm and algae to
study the effect of loss of function. Despite all these efforts, the
functions of most NPHP genes are still largely unknown.
What do NPHP gene products have in common? First, nephro-
cystins localize to primary cilia and centrosomes in renal epithelial
cells. This observation strengthens the ‘unifying theory’ of ciliopa-
thies (Hildebrandt & Zhou, 2007), which suggests that mutant gene
products associated with cystic kidney diseases in humans, mice,
or zebraﬁsh are expressed in primary cilia or centrosomes of renal
epithelial cells. As the eight nephrocystins that are associated with
retinitis pigmentosa are also found in the photoreceptor connect-
ing cilium and basal body, the unifying theory may be expanded
to include photosensitive cilia in the retina.
Second, 9 of 13 nephrocystins carry one or more protein inter-
acting domains. The most frequent protein–protein interaction
motifs identiﬁed in NPHP protein are the coiled coil structural mo-
tif, carried by 7 of 13 nephrocystins, followed by a IQ calmodulin
interacting motif present in NPHP2 and NPHP5, a tetratricopeptide
motif in NPHP3 and NPHP12, a large ankyrin repeat in NPHP2 and a
SH3 interacting motif in NPHP1 (Fig. 2). A key example of a protein
with large numbers coiled-coils is CEP290/NPHP6, known to inter-
act with multiple partners including kinesin motors and transcrip-
tion factors.
Third, mutations in nephrocystins affect trafﬁcking of proteins
in cilia. In photoreceptors, NPHP1 colocalizes with Ac-tubulin in
the connecting cilium. In Nphp1/ mice (del20) (Jiang et al.,
2008) the structure of the cilium was present, but IFT88 and
IFT144 accumulated at the cilium suggesting that NPHP1 may
facilitate the movement of cargo through the cilium by molecular
motors. Consistent with this, rhodopsin and transducin accumulate
in the inner segments and outer segments are not formed. The
accumulation of protein in the inner segment is presumed to trig-
ger apoptotic signals, which leads to retinal cell death and ulti-
mately to widespread retinal degeneration. An excellent examplefor involvement of nephrocystins in trafﬁcking was recently de-
scribed in zebraﬁsh. It was shown that opsin transport was depen-
dent on Inversin/NPHP2 and IQCB1/NPHP5 suggesting that a
NPHP1/2/5 complex may interact with the IFT cargo to facilitate
transport of opsin through the connecting cilium (Zhao & Malicki,
2011). It is conceivable that nephrocystins together with IFT parti-
cles, molecular motor subunits, and adaptor proteins like B9d2
may form large complexes as observed for components to the
BBSome (Nachury et al., 2007).
Finally, it should be noted that the inheritance pattern of neph-
ronophthisis is exclusively recessive suggesting that mutations in
NPHP genes generate null alleles. In the human retina, CEP290/
NPHP6 and IQCB1/NPHP5mutations cause recessive RP or recessive
LCA (Cideciyan et al., 2011), and mouse models with retina pheno-
type (Nphp1/, rd16) are available for gene therapy rescue experi-
ments. Using AAV2/5 vectors, it was shown recently that up to
8.9 kb of DNA can be packaged into viral particles, large enough for
murine Abca4 and human MYO7A proteins (Allocca et al., 2008).
Therefore, even CEP290mutants such as rd16may serve as suitable
animal models to attempt to rescue of LCA in preclinical trials.
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